Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-04-19

Clinical Trial Update: Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

View source ↗

Summary

A pediatric clinical trial investigating cerebrospinal fluid and angiogenesis proteins in newly diagnosed brain and central nervous system tumors has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors | Status: WITHDRAWN